Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2008
05/20/2008US7374927 Methods of analysis of degraded nucleic acid samples
05/20/2008US7374922 Starch debranching enzymes
05/20/2008US7374921 Cellulase tolerant to surfactants
05/20/2008US7374919 Nucleotide sequences coding gylcosyltransferase for identifying modulators for prevention and treatment of rheumatoid arthritis
05/20/2008US7374918 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders
05/20/2008US7374917 Enzymatic polypeptide comprising aldo-keto reductases activity for use in conversion of glucose to vitamin C; bioreactors
05/20/2008US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
05/20/2008US7374893 identifying a peptide that binds to a Co, CoPt, SmCo5 or FePt metal nanoparticle; peptide library of 7-12 residues in length expressed or displayed on the surface of bacteriophage; peptide to control the assembly of inorganic magnetic nanocrystals; microelectronics
05/20/2008US7374888 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents
05/20/2008US7374884 mutant alleles of the angiotensinogen (AGT) gene which cause susceptibility to insulin-dependent diabetes mellitus (IDDM); drug screening, diagnosis
05/20/2008US7374883 Primers, and a probe which is labeled with one fluorescent reporter dye and one quencher dye; incubate specimen, allow amplification of nucleic acid, determine binding of probe to amplified nucleic acid
05/20/2008US7374882 Method for base sequencing and biologically active nucleic acids
05/20/2008US7374877 Amplification of HIV-1 gag sequences for detection of sequences associated with drug-resistance mutations
05/20/2008US7374649 Dispersion of carbon nanotubes by nucleic acids
05/20/2008CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1"
05/20/2008CA2218815C Methods for the production of platinum-based linkers between labels and bio-organic molecules, for labelling bio-organic molecules, for detecting biological substances of interestand diagnostic test kits
05/15/2008WO2008057256A1 Therapeutic treatments based on administration of small rna fragments
05/15/2008WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF
05/15/2008WO2008055347A1 Prediction of potential drug-drug interactions using gene expression profiling of drug transporters, cytochrome p450s and nuclear x receptors
05/15/2008WO2008055341A1 Slc1a1 antipsychotic drug response markers
05/15/2008WO2008034866A3 Dbait and uses thereof
05/15/2008WO2007086935A8 Methods of amplifying and sequencing nucleic acids
05/15/2008WO2007050866A8 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof
05/15/2008WO2005102378A3 Modular furniture system
05/15/2008US20080115242 Genetically Modified Plant Producing Lactosyl Ceramide and Utilization of the Same
05/15/2008US20080115241 Expression vector comprising nucleotide sequences coding latobacillus hydrolase for use in enhancing digestibility of animal feeds
05/15/2008US20080115240 Rna sequences for use targeted gene expression in plants; propagating disease and drought resistant plants
05/15/2008US20080115237 Novel ecdysone receptor-based inducible gene expression system
05/15/2008US20080115231 Using peroxisome proliferator activated receptor as tool in detecting compounds which enhance food intake and/or body weight gain; diagnosing and treating eating disorders
05/15/2008US20080114162 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
05/15/2008US20080114161 Modified probe molecules having self-complementary regions
05/15/2008US20080114160 Expression vector comprising microsatellite sequences encoding restriction fragment length polymorphism for use as tool in enhancing heterologous gene expression in plants
05/15/2008US20080114155 Modified Human Interferon Polypeptides and Their Uses
05/15/2008US20080114154 Protease resistance
05/15/2008US20080113932 Casein kinase 2 antisense therapy
05/15/2008US20080113931 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, substantially complementary to at least part of an mRNA transcript of an Aha gene; cancer or cystic fibrosis
05/15/2008US20080113930 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent
05/15/2008US20080113928 Modified Cea/B7 Vector
05/15/2008US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth
05/15/2008US20080113906 Sushi Peptide Multimer
05/15/2008US20080113449 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders
05/15/2008US20080113430 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
05/15/2008US20080113429 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
05/15/2008US20080113415 Heat resistant thermoanaerobacterium isomerase for use in production of fructose syrup
05/15/2008US20080113412 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
05/15/2008US20080113410 Method for Rational Pegylation of Proteins
05/15/2008US20080113408 Suppressor peptides co-administered with viricidal agents for prevention and treatment of respiratory syncytial viral infection
05/15/2008US20080113406 Modified bacteriocins and methods for their use
05/15/2008US20080113388 Nematode ATP Synthase Subunit E-Like Sequences
05/15/2008US20080113381 Hemoglobin A1c Determination Method, Enzyme to be Used therefor, and Production Method Thereof
05/15/2008US20080113378 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113377 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113376 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113375 siRNA targeting superoxide dismutase 1 (SOD1)
05/15/2008US20080113374 siRNA targeting fructose-1,6-bisphosphatase 1 (FBP1)
05/15/2008US20080113373 siRNA targeting amyloid beta (A4) precursor protein (APP)
05/15/2008US20080113372 siRNA targeting glucagon receptor (GCGR)
05/15/2008US20080113371 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders
05/15/2008US20080113370 siRNA targeting apolipoprotein B (APOB)
05/15/2008US20080113369 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113366 Nucleotide sequences for classification and detection of acinetobacter
05/15/2008US20080113365 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/15/2008US20080113364 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/15/2008US20080113363 Nucleotide sequences for classification and detection of prevotella denticola
05/15/2008US20080113362 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
05/15/2008US20080113361 Post-synthesis processing system for supported oligonucleotides, and method
05/15/2008US20080113356 Method of Separating and Purifying Nucleic Acid
05/15/2008US20080113354 Primer for generating fluorescent products; defective protein screening
05/15/2008US20080113351 Nucleotide sequence for prevention and treatment of cell proliferative disorders; antitumor agents
05/15/2008US20080113349 Method for detecting the presence of mammalian organisms using specific cytochrome c oxidase I (COI) and/or cytochrome b subsequences by a PCR based assay
05/15/2008US20080113347 Using dual specificity protein tyrosine phosphatases (DUSP6) gene expression as diagnostic indicator of nervous system disorders; diagnosing multiple sclerosis
05/15/2008US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic
05/15/2008US20080113345 Microarray expression profiles for use as tool in prognosticating success of tamoxifen therapy
05/15/2008US20080112977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof
05/15/2008US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
05/15/2008US20080112964 Mutant Pneumolysin Proteins
05/15/2008US20080112961 Using antibodies to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy
05/15/2008US20080112959 Smallpox monoclonal antibody
05/15/2008US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals
05/15/2008US20080112943 Biosynthetic Polypeptide Fusion Inhibitors
05/15/2008DE102007045173A1 Nucleotide analogs useful for nucleic acid synthesis or sequencing comprise a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker
05/15/2008DE102006035393A1 Prognostische Marker für die Klassifizierung des dreijährigen progessionsfreien Überlebens von Patienten mit Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben Prognostic markers for the classification of the three-year progessionsfreien survival of patients with colon cancer based on expression profiles of biological samples
05/15/2008CA2668998A1 Prediction of potential drug-drug interactions using gene expression profiling of drug transporters, cytochrome p450s and nuclear x receptors
05/15/2008CA2668961A1 Spink1 as a prostate cancer marker and uses thereof
05/15/2008CA2667149A1 Therapeutic treatments based on administration of small rna fragments
05/15/2008CA2664366A1 Slc1a1 antipsychotic drug response markers
05/14/2008EP1921169A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits
05/14/2008EP1921141A1 Novel artificial base pair and use thereof
05/14/2008EP1920775A1 5'Triphosphate oligonucleotide induces anti-viral response
05/14/2008EP1920065A2 Anti-alpha v beta 6 antibodies and uses thereof
05/14/2008EP1919942A2 Methods and compositions for enhancing protein folding
05/14/2008EP1919931A2 Cellular libraries of peptide sequences (clips) and methods of using the same
05/14/2008EP1919930A2 New nucleic acid base pairs
05/14/2008EP1919514A2 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
05/14/2008EP1919503A2 Identification and engineering of antibodies with variant fc regions and methods of using same
05/14/2008EP1869213A4 Methods and compositions for evaluating graft survival in a solid organ transplant recipient
05/14/2008EP1766021A4 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers
05/14/2008EP1718769A4 Polony fluorescent in situ sequencing beads
05/14/2008EP1711048A4 Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters
05/14/2008EP1660674A4 Expression profiling using microarrays